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Abstract
TIF1c (Transcriptional Intermediary Factor 1 c) has been implicated in Smad-dependent signaling by Transforming Growth
Factor beta (TGF-b). Paradoxically, TIF1c functions both as a transcriptional repressor or as an alternative transcription factor
that promotes TGF-b signaling. Using ordinary differential-equation models, we have investigated the effect of TIF1c on the
dynamics of TGF-b signaling. An integrative model that includes the formation of transient TIF1c-Smad2-Smad4 ternary
complexes is the only one that can account for TGF-b signaling compatible with the different observations reported for
TIF1c. In addition, our model predicts that varying TIF1c/Smad4 ratios play a critical role in the modulation of the
transcriptional signal induced by TGF-b, especially for short stimulation times that mediate higher threshold responses.
Chromatin immunoprecipitation analyses and quantification of the expression of TGF-b target genes as a function TIF1c/
Smad4 ratios fully validate this hypothesis. Our integrative model, which successfully unifies the seemingly opposite roles of
TIF1c, also reveals how changing TIF1c/Smad4 ratios affect the cellular response to stimulation by TGF-b, accounting for a
highly graded determination of cell fate.
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Introduction
Complex signaling by transforming growth factor b(TGF-b)
forms a pivotal network that plays an essential role in tissue
homeostasis and morphogenesis. At the same time, up-regulation
and activity of TGF-b has been linked to various diseases,
including fibrosis and cancer, by promoting cell proliferation and
invasion and the epithelial-mesenchymal transition [1]. TGF-b
signaling occurs through association with a heteromeric complex
of two types of transmembrane serine/threonine kinases, the type I
(TbRI) and type II (TbRII) receptors. TGF-b binding to TbRII
induces recruitment and phosphorylation of TbRI, which in turn
transmits the signal through phosphorylation of the receptor-
bound R-Smad transcription factors, Smad2 or Smad3. Once
phosphorylated, the R-Smads hetero-dimerize with their common
partner, Smad4. The resulting complexes then migrate to the
nucleus, where they regulate the transcription of TGF-b-target
genes in conjunction with other transcription factors [2].
Nuclear Transcriptional Intermediary Factor 1 c, TIF1c (also
known as tripartite motif protein TRIM33), is a member of the
transcriptional intermediary factor 1 family [3] and was recently
identified as a new partner of the Smad-dependent TGF-b
signaling pathway. A screen for molecules involved in the
specification of the embryonic endoderm first revealed TIF1c as
a Smad4-binding protein and as a negative regulator of TGF-b
signaling [4]. TIF1c mono-ubiquitinates Smad4, inducing its
nuclear export to the cytoplasm, where the FAM/UPS9x
deubiquitinating enzyme was recently shown to allow Smad4
recycling [5]. The role of TIF1c as a repressor was also reported in
the control of Smad activity during embryogenesis [6]. In contrast,
TIF1c was identified as a protein partner for receptor-activated
Smad2/3, resulting in an alternative positive regulatory Smad4-
independent TGF-b signaling pathway [7].
Whether TIF1c down-regulates or promotes alternative TGF-b
signaling may be linked to the cellular context. TIF1c is a
ubiquitous protein and its mRNA has been detected in all tissues
[8]. Its loss of expression has been shown to favor Kras
G12D-
dependent precancerous pancreatic lesions [9], induce cell-
autonomous myeloproliferative disorders in mice [10] and
potentiate TIF1a-induced murine hepatocellular carcinoma [11],
thereby supporting a protective role of TIF1c in cancer.
Consistent with this view, a decrease in TIF1c expression in
human pancreatic cancer and human chronic myelomonocytic
leukemia has been reported [9,11] and TIF1c silencing in human
mammary epithelial cell lines was shown to lead to a strong
epithelial-mesenchymal transition mediated by TGF-b1 [12]. In
contrast, a pro-tumorigenesis role for TIF1c has been suggested by
the observation that its expression prevents Smad4-mediated
growth inhibition in response to TGF-b [4]. In line with the
uncertain role of TGF-b in cancer, TIF1c may differentially affect
TGF-b signaling according to the cellular context by acting either
as tumor suppressor or promoter.
Several mathematical models have been developed to predict
the dynamic behavior of TGF-b signaling. In particular, initial
differential models that couple signaling with receptor trafficking
have significantly improved our understanding of the plasticity of
the TGF-b signaling pathway [13]. Models focusing on Smad
phosphorylation [14], Smad nucleocytoplasmic shuttling [15,16]
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understand the dynamics and flexibility of Smad-dependent
pathways, while integrative models have coupled receptor
trafficking to Smad pathways [18–20]. As the latter models
recapitulate the essential components of the canonical Smad-
dependent TGF-b signaling pathway, they constitute useful tools
to investigate the role of new regulatory components of TGF-b
signaling.
We have used an integrative modeling approach to explore the
impact of TIF1c on the outcome of TGF-b signaling. Taking
advantage of mathematical models of receptor trafficking [13] and
Smad shuttling [16], we have developed a new TGF-b signaling
model that includes TIF1c and FAM/UPS9x. Our model, which
is based on the transient formation of a ternary complex
containing TIF1c ¸ Smad4 and Smad2/3, successfully reconciles
the different observations reported for TIF1c-Smad4 [4] and
TIF1c-Smad2/3 [7] interactions. We show that TGF-b signaling
is highly sensitive to the TIF1c/Smad4 ratio, suggesting a critical
role for the FAM/UPS9x deubiquitinase. This model also predicts
how varying TIF1c/Smad4 ratios can modulate the cellular
response to transient and sustained TGF-b stimulation, accounting
for a highly graded TGF-b response. We discuss how the
seemingly opposite roles of TIF1c may be resolved by taking into
account the dynamic balance of interactions involving Smad4 and
Smad2/3.
Materials and Methods
Mathematical modeling
The model consists of a system of nonlinear, ordinary
differential equations that merge the ODE models of receptor
trafficking [13] and Smad shuttling [16]. Briefly, the receptors
described in the Smad shuttling model were replaced by those of
the receptor trafficking model using unit conversion in a cell
volume of 2.27610
212L. Model building, parameters, system
ordinary equations and description of the model in Systems
Biology Markup Language (SBML) are detailed in Tables S1 and
S2 and Model S1. Model simulations were implemented with the
mathematical Scipy library of Python language programming and
the Matplotlib Python 2D plotting library was used to visualize the
simulation curves.
Cell culture and siRNA transfection
Human mammary epithelial (HMEC) cells infected with a
retrovirus carrying hTERT and the oncogenic H-RasV12
(HMEC-TR) allele were provided by R. A. Weinberg [21] and
cultured as previously described [12]. Cells were transfected with
5 nM siRNA and 0.5 ml/ml lipofectamine RNAiMax (Invitrogen)
and further cultured in the presence or absence of 10 ng/ml TGF-
b1 (Peprotech) for the indicated times.
Chromatin immunoprecipitation (ChIP)
Assays were carried out on cells transfected with the PAI-1
p800-Luc construct, as previously described [12], using the kit
from Upstate Biotechnology. Briefly, cell lysates were subjected to
anti-Smad4 (SantaCruz) or anti-TIF1c (Bethyl) immunoprecipita-
tion. Smad4- or TIF1c-precipitated genomic DNA was subjected
to PCR. The 351-bp PAI-1 promoter region harboring the Smad-
binding elements was amplified with primers 59-AGCCAGA-
CAAGGTTGTTG-39 and 59-GACCACCTCCAGGAAAG-39.
An unrelated genomic DNA sequence (actin) was amplified with
primers 59-AGCCATGTACGTTGCTATCCAG-39 and 59-
CTTCTCCTTAATGTCACGCACG-39.
Relative quantification of mRNA by real-time PCR
Real-time quantitative PCR was performed using the qPCRTM
Core Kit for SybrTM Green I from Eurogentec and the ABI
Prism 7700 thermocycler (Perkin-Elmer, Foster city, CA, USA).
Primer pairs for target genes were: sense CDH11 (OB-Cadherin),
59CCC TGA AAT CAT TCA CAA TCC39, antisense 59AGT
CCT GCT TCT GCC GAC T39; CDH2 (N-Cadherin), sense:
59GTG CAT GAA GGA CAG CCT CT39, antisense: 59ATG
CCA TCT TCA TCC ACC TT39; HPRT, sense: 59TGA CCT
TGA TTT ATT TTG CAT ACC39, antisense: 59CGA GCA
AGA CGT TCA GTC CT39.
Western blot analysis
Cell lysates were subjected to SDS-polyacrylamide gel electro-
phoresis and transferred onto PVDF membranes. The blots were
incubated for 1 hr in Tris-buffered saline containing 0.1% Tween
20 and 5% non-fat dry milk and further incubated for 1 hr with
specific primary antibodies (anti-Smad4, SantaCruz biotechnolo-
gy; anti-TIF1c, Euromedex). The bound antibodies were
visualized with horseradish peroxidase–conjugated antibodies
using the ECL-Plus reagent (Roche).
Results and Discussion
Quantitative models for TIF1c-dependent TGF-b
signaling
Merging receptor trafficking [13] and Smad cytonucleoplasmic
shuttling [16] models through their common receptor-ligand
complex in the endosome (LRe), we developed new models that
integrate TIF1c. Kinetic parameters were estimated according to
the experimental data from [5] and [7] and are detailed in Table
S1. We first constructed two separate models, each taking into
account the different hypotheses regarding Smad/TIF1c interac-
tions. The first model is based on the TIF1c-dependent negative
regulation associated with the ubiquitination of Smad4 ([4,5];
Figure 1A). In this model, TIF1c interacts preferentially with
Smad4 within phosphorylated Smad2-Smad4 complexes in
response to TGF-b, leading to a rapid dissociation of complexes
and formation of ubiquitined Smad4 (Smad4ub) that is exported
from the nucleus. Similar to the transient interaction of the
phosphatase (PPase) with phosphorylated Smad2 [15,16], the
formation of TIF1c-Smad complexes was neglected because of fast
reaction rates. In the cytoplasm, ubiquitinated Smad4 undergoes
deubiquitination by FAM/UPS9x (FAM), thereby recycling
Smad4 for TGF-b signaling (Figure 1A). We set the same kinetic
parameters for association between TIF1c and phosphorylated
Smad2-Smad4 complexes in the nucleus (pS2S4n) and association
between phosphorylated Smad2 and Smad4. Ubiquitination/
deubiquitination and phosphorylation/dephosphorylation kinetics
were considered to be similar, as previously described [5]. Export
of ubiquitinated Smad4 from the nucleus to the cytoplasm was
assumed to be 2-fold higher than entry of Smad4 in the nucleus,
based on the observation suggesting that ubiquitined Smad4 is less
efficiently retained in the nucleus [4,5].
Our second model is based on results from He et al. [7], who
proposed that TGF-b induces a competing interaction between
TIF1c and phosphorylated Smad2, although an association of
TIF1c with Smad4 was also detected in the nucleus (Figure 1B). In
the absence of conclusive experimental data, we considered the
kinetic parameters for association between TIF1c and either
phosphorylated Smad2 or Smad4 in the nucleus to be similar to
those for phosphorylated Smad2 with Smad4. To test this
hypothesis, we analyzed the effect of a 2-fold decrease in kon/koff
Regulation of TGF-b Signaling by TIF1c
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did not modify the TGF-b response in simulation studies.
Finally, we integrated the TIF1c and FAM/UPS9x modulators
into a unique model that merges all experimental observations
(Figure 1C). Unlike the model depicted in Figure 1A, we
considered TIF1c binding to Smad4 as part of a ternary complex,
in which phosphorylated Smad2, Smad4 and TIF1c are associated
in the nucleus (pS24nTIF1c). In this case, note that the interaction
of TIF1c with Smad2 occurs within phosphorylated Smad2-TIF1c
(pS2nTIF1c) complexes that are generated by dissociation of the
ternary complexes in the nucleus. We set the same kinetic
parameters for the formation/dissociation of the ternary
pS24nTIF1c complexes and the formation/dissociation of the
phosphorylated Smad2-Smad4 complexes.
Model analysis and simulation
We next performed computational experiments to investigate
the dynamics of TGF-b signaling according to each model. TGF-b
signaling was expressed as the amount of phosphorylated Smad2-
Smad4 complexes in the nucleus (pS24n) because TGF-b target
genes are regulated by these heterodimeric complexes. To explore
the functional effect of TIF1c on the TGF-b transcriptional signal,
simulation studies were performed using different concentrations
of TIF1c varying from 0 to 50 nM, the latter corresponding to the
initial concentration of Smad4 (Figure 2, Table S1). These
prediction studies showed that each model was either too sensitive,
with total inhibition of signaling at low concentrations of TIF1c
according to the first model (Figure 2A), or too insensitive, with
only a slight variation of signaling at higher TIF1c concentrations
according to the second model (Figure 2B). Each predictive model
hence yielded a significant mismatch with the experimental data
derived from the other. The strict negative regulatory role of
TIF1c proposed by Dupont et al. [4] is not compatible with the
lack of sensitivity of the second model adapted from He et al. [7].
Similarly, He et al. observed a moderate TIF1c effect on TGF-b
transcriptional activity that did not agree with the high sensitivity
of the first model adapted from Dupont et al. In contrast, our
integrative model that includes all observations yielded a graded
effect of TIF1c on pS24n complex formation that is in agreement
with the relative abundance of TIF1c-Smad complexes reported in
both studies, leading to a graded regulation of TGF-b signaling
(Figure 2C).
To further explore the robustness of our integrative model, we
evaluated the sensitivity of TGF-b signaling to variations in kinetic
parameters. As shown in Figure 3, varying the rate of formation
(Figure 3A) or dissociation (Figure 3B) of complexes containing
TIF1c and pS24n had little effect on TGF-b signaling. Similarly,
varying the kinetic parameters for the dissociation of phosphor-
ylated Smad2-TIF1c complexes (pS2nTIF1c) induced only few
changes in the concentration of pS24n (Figure 3C). In contrast,
TGF-b signaling was highly sensitive to the variation of kin-
Smad4ub (Figure 3D), suggesting that the export rate of
ubiquitinated Smad4 is a critical component of the regulation of
TGF-b transcriptional activity. In addition, the slight alteration in
TGF-b signaling induced by changes in the deubiquitination rate
of Smad4 (Figure 3E) disappeared with increasing concentrations
of the FAM deubiquitinase (Figure 3F), suggesting that changes in
FAM expression might be a sensitive marker to predict modulation
of TGF-b signaling. Taken together, the results of our simulation
studies reveal a new pivotal role of the Smad4 ubiquitination/
Figure 1. Schematic representation of the models. Detailed information on parameters and entities are given in Tables S1 and S2. A) Model
hypothesis from [4]. B) Model hypothesis from [7]. C) Integrated model including TIF1c (red rectangle) and FAM (green rectangle).
doi:10.1371/journal.pone.0033761.g001
Figure 2. Effect of TIF1c on TGF-b signaling. Modeling analysis of
the pS24n response to increasing TIF1c concentrations at a 10 nM TGF-
b input. A) Model according to [4]; B) model according to [7] and C)
integrated model.
doi:10.1371/journal.pone.0033761.g002
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PLoS ONE | www.plosone.org 4 March 2012 | Volume 7 | Issue 3 | e33761Figure 3. Parameter sensitivity analysis. Modeling analysis of pS24n response to variations of kinetic constants at a 10 nM TGF-b input. A) kon-
pS24nTIF1c, binding of TIF1c to phosphorylated-Smad2/Smad4 complexes; B) koff-pS24nTIF1c, dissociation of phosphorylated-Smad2/Smad4/TIF1c
complexes in the nucleus; C) koff-pS2nTIF1c, dissociation of phosphorylated Smad2-TIF1c complexes in the nucleus; D) kin-S4ub, nuclear export of
ubiquitinated Smad4 in the cytoplasm; E) and F) kdub, deubiquitination of Smad4 according to relative FAM concentrations of 1 nM (E) and 10 nM (F).
doi:10.1371/journal.pone.0033761.g003
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signaling. Of note is the predicted critical regulatory role of FAM
in TGF-b signaling through Smad4 recycling.
Experimental validation of the model
A key component of our model is based on the hypothesis that a
transient ternary complex is formed, associating Smad4, TIF1c
and Smad2. To investigate the reality of such an interaction, we
performed chromatin immunoprecipation (ChIP) assays as
previously described [12]. As shown in Figure 4, stimulation of
cells with TGF-b induced the recruitment of Smad proteins on the
promoter sequence of PAI-1, a TGF-b target gene. In the absence
of TGF-b stimulation, TIF1c showed a significant association with
DNA while Smad2/3 was not detected. A faint Smad4 signal
could be detected under these conditions. TGF-b stimulation led
to the detection of a strong Smad2/3 ChIP signal. Between 30 and
90 min of TGF-b stimulation, the association of all three proteins
with DNA appears consistent with the hypothesis that a ternary
complex containing Smad4, Smad2/3 and TIF1c transiently
forms. After 120 min, Smad4 dissociated from DNA whereas
Smad2/3 and TIF1c remained present on the PAI-1 promoter.
This observation is in agreement with our hypothesis that Smad2-
TIF1c complexes are released from the ternary complexes.
Importantly, Dupont et al. [4], using a double-immunoprecipita-
tion approach for TIF1c and Smad4, previously reported
formation of these ternary complexes. More recently TIF1c was
shown to be present at the promoter region of PAI-1 gene in
uninduced cells, whereas an increase in TIF1c association with the
Smad-binding region of the promoter was also observed upon
TGF-b stimulation [22].
We next devised an experimental approach that could be used
to evaluate TGF-b transcriptional activity as a function of variable
TIF1c/Smad4 ratios. Cells were transiently transfected with
siRNAs to silence Smad4 or TIF1c expression and were further
stimulated or not with TGF-b for the indicated times (Figure 5A).
The expression of Smad4 and TIF1c was efficiently inhibited since
no proteins were detected at day 3 post-transfection compared
with cell transfected with non-targeted siRNAs (scr). The efficacy
of RNA interference was confirmed at the mRNA level (Figure
S1). This effect decreased with time according to siRNA
availability and mRNA turnover, leading to the recovery of
protein basal levels after several days (Figure 5A, upper panel).
Note that silencing Smad4 and TIF1c affected the amounts of
TIF1c and Smad4 proteins, respectively, detected at day 3. The
time courses shown in Figure 5 finally allowed us to analyze cells
containing variable amounts of endogenous Smad4 and TIF1c
proteins. For each time point, cell extracts were used for western
blot analyses and TIF1c/Smad ratios were evaluated by
densitometric scanning of blots (Figure 5A, bottom panel). To
perform this experimental verification, we quantified the mRNA
levels of endogenous TGF-b target genes instead of using the over-
expression of reporter genes to estimate transcriptional activities.
We selected the CDH2 and CDH11 cadherin genes as they are
up-regulated by TGF-b through Smad4- and TIF1c-dependent
pathways in our cell model (Figure S2). Using the same cell
extracts used for western blotting (Figure 5A), the mRNA levels of
CDH2 and CDH11 were quantified and TGF-b transcriptional
activity was evaluated as the ratio of mRNA levels observed in the
presence or absence of TGF-b (Figure 5B). TGF-b-induced
expression of CDH2 and CDH11 was correlated with the amount
of Smad4 and TIF1c proteins. Compared to control cells (scr), low
Smad4 expression (Day3) prevented TGF-b-dependent expression
of CDH2 and CDH11 while the absence of TIF1c led to up-
regulation of CDH2 and CDH11.
We then compared these experimental data with results
predicted by our integrative model. As shown in Figure 5C, our
observations could be fitted to the simulation curves of TGF-b
transcriptional signaling, a validation reinforced by the use of
physiological parameters. We conclude from these results that
TIF1c is a new regulator that plays a pivotal role in the control of
Smad4-dependent TGF-b transcriptional activity. These data also
show that TIF1c/Smad4 ratios can determine TGF-b-dependent
transcriptional activity. Accordingly, our model supports the
hypothesis of fast binding of TIF1c to phosphorylated Smad2/
Smad4 complexes and the release of both ubiquitinated Smad4
and phosphorylated Smad2-TIF1c complexes.
TGF-b dose- and time-dependent responses
The concentration of TGF-b in the cellular microenvironment
is highly variable and its increased expression has been reported in
numerous pathologies, including inflammation, fibrosis and cancer
[23]. However the determination of TGF-b concentrations at the
cellular level within tissues remains a difficult task since TGF-b is
stocked as a latent form in the extracellular matrix [24]. In
addition, its conversion from latent to biologically active forms
involves numerous protease- and non protease-dependent mech-
anisms that differ according to cell type and the physiological
context, leading to a complex non-linear delivery [25]. All
previous mathematical models are based on biological data
obtained from in vitro experiments using either TGF-b concentra-
tions (in the nM range) or on/off signal inputs. However, Zi and
al. [19] recently developed an integrative model that includes a
ligand depletion parameter and demonstrated that cell-fate
decision in response to TGF-b stimulation depends not only on
its concentration but also on the time course of its delivery.
Because we did not integrate ligand depletion in our model,
response predictions were insensitive to TGF-b concentration
except for concentrations as low as 0.1 nM (Figure 6A) and we
routinely used concentrations of 10 nM as the TGF-b input.
Figure 4. TIF1c, Smad2 and Smad4 bind to the PAI-1 promoter.
ChIP assays were performed on HMEC cells treated with TGF-b for the
indicated times. Cell lysates were subjected to anti-Smad4 (IP Smad4),
or anti-TIF1c (IP TIF1c), or anti-Smad2/3 (IP Smad2/3) chromatin
immunoprecipitation. PCR amplification of the endogenous PAI-1
promoter (733/484) was performed to detect protein bound DNA.
Primers specific to actin were used as controls.
doi:10.1371/journal.pone.0033761.g004
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PLoS ONE | www.plosone.org 6 March 2012 | Volume 7 | Issue 3 | e33761Figure 5. Expression of the CDH2 and CDH11 TGF-b target genes is sensitive to TIF1c/Smad4 ratios. HMEC cells were transfected with
Smad4 (siSmad4) or TIF1c (siTIF1c) siRNAs and cultured in the presence (+) or absence (2) of TGF-b for the indicated times (days). Controls were cells
transfected with non-targeted siRNA (scr). A) Smad4 and TIF1c protein levels were analyzed by immunoblotting (upper panels) and quantified by
densitometric scanning (lower panels). B) TGF-b-induced fold changes in CDH2 and CDH11 expression were analyzed by RT–qPCR. All values were
normalized to the amount of HPRT mRNA and expressed relative to the value obtained for TGF-b-untreated controls in arbitrary units (AU). Results are
expressed as the mean 6 SD of 3 independent experiments. C) mRNA levels of CDH2 (red circles) and CDH11(blue circles) were plotted against TIF1c/
Smad4 ratios and were fitted to the predictive equation curve of pS24n relative concentrations.
doi:10.1371/journal.pone.0033761.g005
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short-term and switch-like long-term responses to TGF-b were
conserved as reported by Zi et al. [19]. However, they were
attenuated, suggesting that the presence of TIF1c does not affect
the signal shape, but only the amplitude of TGF-b signaling
(Figure S3).
In contrast, we observed that, in our model, the length of
stimulation modified the cell response. This was particularly true
for short times (Figure 6B), maximum pS24n complex formation
being highly dependent on TIF1c concentration (Figure 6C and
6D). This indicates that the magnitude of the cellular response to
TGF-b depends on both TIF1c/Smad4 ratios and time-
dependent stimulation, predicting a broad range of responses
according to TGF-b cellular content and availability in the
microenvironment (Figure 7A). Note that the alternative
pS2TIF1c transcription complexes proposed by He et al. [7]
displayed an opposite profile that required high TIF1c/Smad4
ratios and longer stimulation times to be fully active (Figure 7B).
In agreement with Zi et al. [19], our model showed that periodic
short pulses of ligand stimulation yielded an outcome similar to
that produced by sustained ligand simulation, whereas an increase
in the duration between pulses prevented a continuous response.
These observations support the memory concept of ligand-
receptor complex (LCR) activity (Figure S4A). When TIF1c was
added, the shape of the response was similar, albeit attenuated,
suggesting that, in our model, TIF1c does not affect LCR
recycling (Figure S4B).
Conclusions
Taking into account the seemingly contradictory observations
of Smad4-TIF1c and Smad2/3-TIF1c interactions, we propose
an integrative model based on the formation of Smad2-Smad4-
TIF1c ternary complexes. Validation of our hypotheses by a
posteriori biological experiments provides strong support for our
model, which shows that the TIF1c/Smad4 ratio serves as a
regulator of TGF-b signaling that may affect determination of cell
Figure 6. Concentration and time dependence of TGF-b signaling. A) and B) Modeling analysis of the pS24n response to increasing
concentrations of TGF-b (A) and duration of stimulation with 10 nM TGF-b (B). C) and D) Modeling analysis of the maximum pS24n response as a
function of TGF-b duration of exposure (C) or increasing TIF1c/Smad4 ratios (D).
doi:10.1371/journal.pone.0033761.g006
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highly sensitive to TIF1c/Smad4 ratios, especially for short
stimulation times that mediate higher threshold responses. A
critical role for the TIF1c/Smad4 ratio in the regulation of TGF-
b signaling is supported by the antagonistic role of TIF1c and
Smad4 in the epithelio-mesenchymal cell transition [12],
embryonic patterning and trophoblast stem-cell differentiation
[6], suggesting that TIF1c acts as a negative regulator of higher
TGF-b threshold responses.
Our results emphasize the significance of TIF1c in orchestrating
the pleiotropic effects of TGF-b signaling according to the cellular
context. Its sensitivity to Smad4 levels and stimulation times
suggests that TIF1c helps define a broad landscape of TGF-b
responses. We note that Agricola et al. recently proposed a new
Figure 7. TGF-b time-dependent pS24n and pS2nTIF1c response profiles as a function of TIF1c/Smad4 ratios. Results are expressed as
percentage of the maximum production of pS24n (A) or pS2nTIF1c (B).
doi:10.1371/journal.pone.0033761.g007
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PLoS ONE | www.plosone.org 9 March 2012 | Volume 7 | Issue 3 | e33761model for TIF1c ubiquitin ligase activity that requires binding to
histones [22], thus implicating chromatin dynamics in the control
of Smad localization at the promoter of TGF-b target genes.
According to these results, epigenetic events contribute to the
transcriptional regulation of TGF-b target genes via acetylation
and methylation processes [26–28]. In order to understand the
complexity of TGF-b-dependent gene regulation and to predict
cellular responses, we believe that future models will need to
integrate not only the Smad canonical pathway but also Smad-
independent pathways and epigenetic events. Because of the lack
of quantitative data, such an ambitious goal will require the
development of different modeling-based approaches that utilize
discrete models [29,30].
Supporting Information
Figure S1 Effects of Smad4 and TIF1c knockdown on
gene expression. HMEC cells were transfected with Smad4
(siSmad4) or TIF1c (siTIF1c) siRNAs and cultured in the presence
(+) or absence (2) of TGF-b for the indicated times (days).
Controls were cells transfected with non-targeted siRNA (Scr).
Smad4 and TIF1c gene expression was quantified by RT-qPCR.
All values were normalized to the amount of HPRT mRNA and
expressed in arbitrary units (AU). Results are expressed as the
mean+SD of 3 independent experiments.
(PDF)
Figure S2 Expression of the CDH2 and CDH11 is
induced by TGF-b through TIF1c- and Smad4-dependent
pathways. HMEC cells were transfected with Smad4 (siSmad4)
or TIF1c siRNAs (si TIF1c) and cultured in the presence (+)o r
absence (2) of TGF-b for 2 days. Control cells transfected with
non-targeted siRNA (Scr). CH2 and CDH11 gene expression was
quantified by RT-qPCR. Results are normalized to the amount of
mRNA in untreated cells and expressed as the mean+SD of 3
independent experiments.
(PDF)
Figure S3 TIF1c does not affect short-term and switch-
like long-term responses to TGF-b. TGF-b depletion was
added to the integrated model and modeling analysis of the pS24n
response was performed using either increasing concentrations of
TGF-b (A) or increasing concentrations of TIF1c in the presence
of 1 nM (B) 5 nM (C) and 10 nM TGF-b (D).
(PDF)
Figure S4 TIF1c does not modify the pS24n response to
a pulsed exposure to TGF-b. Model prediction of the pS24n
response in the absence (A) or presence (B) of 10 nM TIF1c to
sustained TGF-b (10 nM) stimulation (blue curve), continuous
short pulses at 30-minute intervals (green curve) or 3-hour
intervals (red curve), as previously described experimentally (Zi
et al 2011). We use 10 nM TIF1c as an average dose of tested
concentrations. Concentrations up to 50 nM TIF1c did not
modify the behavior of the signal but only reduced the signal
range.
(PDF)
Table S1 System parameters.
(PDF)
Table S2 System of ordinary differential equations.
Equations in black are from Vilar et al., 2006 and Schmierer et al.,
2008; equations in red are estimated from biological experiments
from Dupont et al., 2005, 09 and He et al., 2006.
(PDF)
Model S1 Description of the model in Systems Biology
Markup Language (SBML).
(PDF)
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